We found that for patient P19, who had C-SCLC, most cells highly expressed not only the NET markers CHGA, CHGB, ASCL1, and NEUROD1 but also the ADC marker NAPSA. Only a small fraction of cancer cells solely expressed ADC markers. Here, NEUROD1 is linked to cancer.